← Back to Search

Exercise Program for Cancer Management (WELL-FIT Trial)

N/A
Waitlist Available
Led By Caryl Russell, MSc
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 sessions (12 weeks)
Awards & highlights

WELL-FIT Trial Summary

This trial is testing whether exercise and education can help manage cancer treatment side effects.

Who is the study for?
This trial is for individuals who have been diagnosed with cancer and are currently undergoing treatment such as chemotherapy, radiation therapy, or hormonal therapy. Participants must be able to exercise and have their doctor's approval to join.Check my eligibility
What is being tested?
The UW WELL-FIT program is testing the effectiveness of cardiovascular and resistance exercises combined with educational sessions in managing side effects of cancer treatments. The outcomes will contribute to ongoing research.See study design
What are the potential side effects?
Since this trial involves an exercise program, potential side effects may include muscle soreness, fatigue, and risk of injury if not performed correctly. However, these risks are generally low when supervised by professionals.

WELL-FIT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 sessions (12 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 sessions (12 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body Mass Index
Maximal Exercise Test
Percent Body Fat
+1 more
Secondary outcome measures
Glucose
Lipids

WELL-FIT Trial Design

1Treatment groups
Experimental Treatment
Group I: Cardiovascular and strength training exerciseExperimental Treatment1 Intervention
24 sessions (~12 weeks) exercise
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760

Find a Location

Who is running the clinical trial?

University of WaterlooLead Sponsor
123 Previous Clinical Trials
209,581 Total Patients Enrolled
Caryl Russell, MScPrincipal InvestigatorUniversity of Waterloo
Michael Sharratt, PhDPrincipal InvestigatorUniversity of Waterloo

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT02734394 — N/A
Cancer Research Study Groups: Cardiovascular and strength training exercise
Cancer Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT02734394 — N/A
Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT02734394 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there openings within this medical experiment for volunteers?

"According to clinicaltrials.gov, this trial is no longer actively recruiting patients despite initially being posted on June 1st 2014 and last edited on August 30th 2022. Fortunately, there are 486 other studies that are still open for enrollment at present."

Answered by AI
~11 spots leftby Dec 2024